Merck & Company
(MRK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,825,000 | 14,526,000 | 11,508,000 | 8,256,000 | 4,307,000 |
| Depreciation Amortization | 991,000 | 3,909,000 | 3,017,000 | 2,058,000 | 1,120,000 |
| Income taxes - deferred | -277,000 | -1,568,000 | -1,261,000 | -600,000 | -338,000 |
| Accounts receivable | N/A | -644,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -289,000 | N/A | N/A | N/A |
| Other Working Capital | -2,890,000 | -2,782,000 | -2,435,000 | -2,698,000 | -1,299,000 |
| Other Operating Activity | 690,000 | 5,943,000 | 3,836,000 | 2,047,000 | 971,000 |
| Operating Cash Flow | $1,339,000 | $19,095,000 | $14,665,000 | $9,063,000 | $4,761,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -62,000 | -483,000 | -1,000 | -331,000 | -371,000 |
| PPE Investments | -1,007,000 | -4,388,000 | -3,239,000 | -2,113,000 | -984,000 |
| Net Acquisitions | -1,327,000 | N/A | -121,000 | N/A | N/A |
| Other Investing Activity | 37,000 | -89,000 | 149,000 | 194,000 | 182,000 |
| Investing Cash Flow | $-2,359,000 | $-4,960,000 | $-3,212,000 | $-2,250,000 | $-1,173,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,000 | -2,251,000 | -2,250,000 | -1,250,000 | -1,250,000 |
| Common Stock Issued | 30,000 | 384,000 | 119,000 | 109,000 | 12,000 |
| Common Stock Repurchased | -149,000 | N/A | N/A | N/A | N/A |
| Dividend Paid | -1,853,000 | -7,012,000 | -5,262,000 | -3,515,000 | -1,745,000 |
| Other Financing Activity | -81,000 | -240,000 | -172,000 | -207,000 | -103,000 |
| Financing Cash Flow | $-2,054,000 | $-9,119,000 | $-7,565,000 | $-4,863,000 | $-3,086,000 |
| Exchange Rate Effect | 87,000 | -410,000 | -776,000 | -364,000 | -55,000 |
| Beginning Cash Position | 12,773,000 | 8,167,000 | 8,167,000 | 8,167,000 | 8,167,000 |
| End Cash Position | 9,786,000 | 12,773,000 | 11,279,000 | 9,753,000 | 8,614,000 |
| Net Cash Flow | $-2,987,000 | $4,606,000 | $3,112,000 | $1,586,000 | $447,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,339,000 | 19,095,000 | 14,665,000 | 9,063,000 | 4,761,000 |
| Capital Expenditure | -1,007,000 | -4,388,000 | -3,239,000 | -2,113,000 | -984,000 |
| Free Cash Flow | 332,000 | 14,707,000 | 11,426,000 | 6,950,000 | 3,777,000 |